Trial Profile
Adjuvant antineoplastics +/- darbepoetin alfa in women with node-positive breast cancer
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 May 2015
Price :
$35
*
At a glance
- Drugs Darbepoetin alfa (Primary) ; Cyclophosphamide; Docetaxel; Doxorubicin; Epirubicin; Fluorouracil
- Indications Early breast cancer
- Focus Therapeutic Use
- Acronyms WSG-ARA Plus
- 01 Jan 2014 Status changed from active, no longer recruiting to completed according to results published in the Annals of Oncology.
- 05 Jan 2012 New trial record
- 10 Dec 2011 Results presented at the 34th Annual San Antonio Breast Cancer Symposium.